111, Inc. (NASDAQ: YI) Stock Competitors & Peer Comparison
See YI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for YI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| YI | $3.09 | -1.90% | 27M | -1.86 | -$1.66 | N/A |
| MCK | $921.67 | +0.68% | 107.9B | 22.58 | $40.82 | +0.37% |
| COR | $316.37 | +0.46% | 61.6B | 18.45 | $17.15 | +0.76% |
| CAH | $233.44 | +0.14% | 54.7B | 22.38 | $10.43 | +0.88% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $84.84 | +0.72% | 9.7B | 15.98 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| AHG | $1.17 | +0.86% | 999.2M | -5.48 | -$0.21 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| EMPG | $17.36 | +0.00% | 143M | 192.89 | $0.09 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
YI vs MCK Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, MCK has a market cap of 107.9B. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while MCK trades at $921.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas MCK's P/E ratio is 22.58. In terms of profitability, YI's ROE is +0.24%, compared to MCK's ROE of -1.94%. Regarding short-term risk, YI is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for YI.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
YI vs COR Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, COR has a market cap of 61.6B. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while COR trades at $316.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas COR's P/E ratio is 18.45. In terms of profitability, YI's ROE is +0.24%, compared to COR's ROE of +1.06%. Regarding short-term risk, YI is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for YI.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
YI vs CAH Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, CAH has a market cap of 54.7B. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while CAH trades at $233.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas CAH's P/E ratio is 22.38. In terms of profitability, YI's ROE is +0.24%, compared to CAH's ROE of -0.60%. Regarding short-term risk, YI is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for YI.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
YI vs ABC Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas ABC's P/E ratio is 21.92. In terms of profitability, YI's ROE is +0.24%, compared to ABC's ROE of +1.06%. Regarding short-term risk, YI is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for YI.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
YI vs HSIC Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, HSIC has a market cap of 9.7B. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while HSIC trades at $84.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas HSIC's P/E ratio is 15.98. In terms of profitability, YI's ROE is +0.24%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, YI is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for YI.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
YI vs PDCO Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas PDCO's P/E ratio is 20.48. In terms of profitability, YI's ROE is +0.24%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, YI is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for YI.Check PDCO's competition here
Akso Health Group (NASDAQ: AHG)
YI vs AHG Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, AHG has a market cap of 999.2M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while AHG trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas AHG's P/E ratio is -5.48. In terms of profitability, YI's ROE is +0.24%, compared to AHG's ROE of -0.50%. Regarding short-term risk, YI is less volatile compared to AHG. This indicates lower risk in terms of short-term price fluctuations for YI.Check AHG's competition here
Owens & Minor, Inc. (NYSE: OMI)
YI vs OMI Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas OMI's P/E ratio is -0.47. In terms of profitability, YI's ROE is +0.24%, compared to OMI's ROE of +0.63%. Regarding short-term risk, YI is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for YI.Check OMI's competition here
Empro Group Inc. Ordinary shares (NASDAQ: EMPG)
YI vs EMPG Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while EMPG trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas EMPG's P/E ratio is 192.89. In terms of profitability, YI's ROE is +0.24%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, YI is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for YI.Check EMPG's competition here
Akso Health Group (NASDAQ: HX)
YI vs HX Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas HX's P/E ratio is -1.84. In terms of profitability, YI's ROE is +0.24%, compared to HX's ROE of -1.07%. Regarding short-term risk, YI is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for YI.Check HX's competition here
Accendra Health, Inc. (NYSE: ACH)
YI vs ACH Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, ACH has a market cap of 35.7M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while ACH trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas ACH's P/E ratio is 0.69. In terms of profitability, YI's ROE is +0.24%, compared to ACH's ROE of +0.63%. Regarding short-term risk, YI is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for YI.Check ACH's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
YI vs WGRX Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas WGRX's P/E ratio is -0.33. In terms of profitability, YI's ROE is +0.24%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, YI is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for YI.Check WGRX's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
YI vs MEDS Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, MEDS has a market cap of 8.1M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while MEDS trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas MEDS's P/E ratio is N/A. In terms of profitability, YI's ROE is +0.24%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, YI is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for YI.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
YI vs ZYXI Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, YI's ROE is +0.24%, compared to ZYXI's ROE of +3.14%. Regarding short-term risk, YI is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for YI.Check ZYXI's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
YI vs HKPD Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, HKPD has a market cap of 1.1M. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while HKPD trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas HKPD's P/E ratio is -1.44. In terms of profitability, YI's ROE is +0.24%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, YI is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for YI.Check HKPD's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
YI vs SNYR Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, SNYR has a market cap of 941.8K. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while SNYR trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas SNYR's P/E ratio is -0.06. In terms of profitability, YI's ROE is +0.24%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, YI is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for YI.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
YI vs RDGT Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, RDGT has a market cap of 836K. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while RDGT trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas RDGT's P/E ratio is -0.02. In terms of profitability, YI's ROE is +0.24%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, YI is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for YI.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
YI vs CVET Comparison October 2026
111, Inc. (NASDAQ: YI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, YI stands at 27M. In comparison, CVET has a market cap of 0. Regarding current trading prices, YI is priced at $3.09 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
YI currently has a P/E ratio of -1.86, whereas CVET's P/E ratio is -69.97. In terms of profitability, YI's ROE is +0.24%, compared to CVET's ROE of -0.06%. Regarding short-term risk, YI is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for YI.Check CVET's competition here